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ABSTRACT 
The metabolic syndrome is characterized by several cardiovascular risk factors and is associated with an increased incidence of 
diabetes, cardiovascular events and mortality. The prevalence of metabolic syndrome is increasing in epidemic proportions 
worldwide. The present study aimed to investigate the prevalence of metabolic syndrome and its components in healthy 
populations in Sana'a, Yemen. This study was a cross-sectional study conducted from February 2019 to April 2019. A total of 120 
healthy populations (40 years≤ old) were selected. The study protocol was approved by the institutional ethical committee and 
informed consent was obtained from all the enrolled study patients for their inclusion in the screening and participation in the 
research. In the present study, the diagnosis of metabolic syndrome based on the American Heart Association/National Heart, 
Lung, and Blood Institute (AHA/NHLBI) and to a joint statement from several large organizations. In the current study, the 
presence of more than or equal to any three of the above mentioned factors is required for the diagnosis of metabolic syndrome. 
The total prevalence of metabolic syndrome among the study subjects was 40.0% (P<0.001) and 62.5% of them were within 40-49 
years old. In the present study, there was not statically significant difference between the khat chewing and the metabolic 
syndrome. According the distribution of metabolic syndrome criteria among subjects with metabolic syndrome, the prevalence of 
fasting blood glucose (FBG) was the highest (85%). The prevalence of metabolic syndrome among healthy Yemeni populations 
was very high and it is associated with increased morbidity and mortality.  This emphasizes the need for more attention to 
investigate this condition to decreasing the prevalence of cardiovascular morbidity and mortality in these subjects. 
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INTRODUCTION 
Metabolic syndrome was first identified during the late 
1980s and was characterized by the clustering of 
abdominal obesity, elevated blood pressure, 
hyperglycemia, and dyslipidemia
1
. Subjects with 
metabolic syndrome are at increased risk for coronary 
artery disease (CAD), and the present of metabolic 
syndrome can increase the risk of all new-onset 
cardiovascular disease (CVD) by 25 %
2
. In addition, 
metabolic syndrome is associated with an increased 
risk of death from coronary heart diseases, 
cardiovascular diseases, and all other causes
3
. 
Metabolic syndrome increases the risk of type 2 
diabetes mellitus and cardiovascular disease (CVD) by 
a 5-fold and 2-fold, respectively during the next 5 to 10 
years
4
. Recently, the prevalence of metabolic syndrome 
has been reported to be between 10% and 84% globally 
according to the age, sex, and races of the population
5
. 
About twenty-five percent of adults in the U.S. have 
the metabolic syndrome
6
. The prevalence of metabolic 
syndrome in the Middle East and North African 
(MENA) region is known for its high, where it has 
been reported to be 45.5% and 24.3% in Tunisia, using 
the International Diabetes Federation (IDF) criteria and 
Adult Treatment Panel (ATP III) definition, 
respectively
7
. The prevalence of metabolic syndrome in 
Gulf countries, as part of the Middle East, has shown 
ranges from 17% in Oman
8 
to 40.5% in the United 
Arab Emirates (UAE)
9
, according to the ATP III and 
IDF criteria, respectively. 
According to Al-Rubeaan et al., the prevalence of 
metabolic syndrome in Saudi Arabia was 39.8% and 
31.6% in 2018, depending on the ATP III and IDF 
criteria
10
. The metabolic syndrome is recognized as a 
significant public-health problem. Due to changes in 
the social environment, the numbers of people with 
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metabolic syndrome have been increased during the 
past years. Therefore, the main aim of the current study 
was to estimate the prevalence of metabolic syndrome 
and its risk factors among the adult Yemeni population 
in comparison to other countries. 
 
METHODS 
This study was a cross-sectional study conducted from 
February 2019 to May 2019. A total of 120 of healthy 
populations (40 years≤ old) were selected. Full ethical 
clearance was obtained from the qualified authorities 
who approved the study design and the informed 
consent was obtained from all the study subjects for 
their inclusion in the screening and participation in the 
research. 
 
Figure 1: Prevalence of metabolic syndrome among 
the study sample among gender and waist 
circumference 
To institute the metabolic syndrome into clinical 
practice, several scientific organizations have 
attempted to introduce definition of the syndrome. In 
the present study, the diagnosis of metabolic syndrome 
based on the American Heart Association/National 
Heart, Lung, and Blood Institute (AHA/NHLBI) and to 
a joint statement from several large organizations
11
. 
The patients must meet at least three of the following 
criteria for diagnosis of metabolic syndrome: 
 Increased waist circumference (40 inches [102 cm] 
or greater in men and 35 inches [89 cm] or greater 
in women). 
 Triglycerides of 150 mg/dL (1.70 mmol/L) or 
greater. 
 Low high-density lipoprotein (HDL) cholesterol 
(less than 40 mg/dL[1.03 mmol/L] in men and less 
than 50 mg/dL [1.29 mmol/L] in women). 
 Systolic blood pressure (BP) of 130 mm Hg or 
greater, diastolic BP of 85 mm Hg or greater. 
 Fasting blood glucose of 100 mg/dL (5.6 mmol/L) 
or greater. 
Table 1: Prevalence of metabolic syndrome among 
the study populations 
Variable Level of 
variable 
N % P-value 
 
Metabolic 
Syndrome 
Yes 48 40.0  
0.001 No 72 60.0 
Total 120 100.0 
In the current study, the presence of more than or equal 
to any three of the above mentioned factors is required 
for the diagnosis of metabolic syndrome. Populations 
with established chronic diseases were excluded to 
homogenize the study subjects. 
Table 2: The prevalence of metabolic syndrome 
among gender 
Variable 
 
Metabolic 
Syndrome 
Total P-
value 
Yes No 
Gender 
 
Male 21 (30.4%) 48  69 0.013 
Female 27 (52.9%) 24 51 
Total 48 72 120 
Waist 
circumf
erence 
(WC) 
No 22 60 82 0.001 
Yes 26 12 38 
Total 48 72 168 
 
All the study subjects were personally interviewed by 
the trained interviewers. The following variables were 
evaluated: age, sex, waist circumference, HDL 
cholesterol, triglycerides, fasting glucose, and blood 
pressure. Statistical analysis was done by SPSS 
software version 21.0 by using Pearson’s Chi-square 
test. Categorical variables were expressed as 
percentages. P-value of less than 0.05 was considered 
significant. 
Table 3: The prevalence of different variables 
among subjects with metabolic syndrome 
P-
value 
Total Metabolic 
Syndrome 
 
Variable 
Yes No 
 
0.001 
69 17 52 No Triglyceride 
51 31 20 Yes 
120 48 72 Total 
 
0.001 
69 32 37 Yes HDL- 
Cholesterol 51 40 11 No 
120 72 48 Total 
 
0.001 
81 23 58 No Blood Pressure 
(BP) 39 25 14 Yes 
120 48 72 Total 
 
0.001 
46 7 39 No Fasting Blood 
Glucose 
(FBG) 
74 41 33 Yes 
120 48 72 Total 
 
RESULTS 
The overall prevalence of metabolic syndrome was 
40% (P-value < 0.001), and was significantly higher in 
women than in men (52.9%  vs 30.4%, respectively; P-
value=0.01). Out of 69 males, 21 (30.4%) had 
Metabolic Syndrome and 27 (52.9%) of females had 
metabolic syndrome (Table 2).  
There was significantly relationship between the 
prevalence of waist circumference and metabolic 
syndrome (P-value<0.001). 26 of patients with 
increased waist circumference had metabolic 
syndrome, in comparison, 22 of patients with metabolic 
syndrome did not have increased waist circumference. 
Table 3 showed the distribution of metabolic syndrome 
by Triglyceride. Results in this table indicated that the 
relationship between metabolic syndrome and 
prevalence of triglyceride was high significant (P-
value< 0.001). In addition, out of 48 subjects with 
metabolic syndrome, 31 of them had high triglyceride. 
The relationship between metabolic syndrome and 
HDL cholesterol level was statistically significant (P-
 Alyahawi et al.                                                                   Universal Journal of Pharmaceutical Research                          
 ISSN: 2456-8058                                                           51                                     CODEN (USA): UJPRA3               
value<0.001). According to the study findings, 
37(77.1%) of subjects with metabolic syndrome had 
low HDL (<40 mg/dL in male or <50 in female). 
However, 11 of subjects with metabolic syndrome had 
normal HDL cholesterol level. 
Table 4: The distribution of age group, smoking, 
and khat chewing among patients with metabolic 
syndrome 
Variable Metabolic 
Syndrome 
Total P-
value 
 Yes      No   
Age 
group 
40-49 30 47 77  
 
0.113 
50-59 10 21 31 
60 or 
greater 
8 4 12 
Smoking Yes  18 22 40  
0.429 No  30 50 80 
Khat 
chewing 
Yes  34 14 48  
0.124 No  41 31 72 
The association between metabolic syndrome and 
blood pressure was analyzed in the Table 7. Results in 
this table showed high significantly relationship (P-
value<0.001). Based on the study results, 25 (52.1%) 
of subjects with metabolic syndrome had high blood 
pressure. In the current study, the relationship between 
metabolic syndrome and fasting blood glucose (FBG) 
was statistically significant (P-value< 0.001). In 
addition, 41 (85.4%) of subjects with metabolic 
syndrome had high FBG.  In this study, the relationship 
between metabolic syndrome and age group was not 
statistically significant (P-value=0.113). Similarly, 
there was not any relationship between metabolic 
syndrome and Khat chewing or smoking (P-
value=0.124; 0.420, respectively). 
Table 5: Distribution of metabolic syndrome 
criteria among subjects with metabolic syndrome 
Variable Metabolic 
Syndrome 
% 
Yes  No  
Waist 
Circumference 
No 22 60  
54.2 Yes  26 12 
Triglyceride No  17 52  
67.6 Yes  31 20 
HDL-C Yes 37 32  
77.1 No  11 40 
Blood 
Pressure 
No  23 58  
52.1 Yes  25 14 
Fasting Blood 
Glucose 
No  7 39 85 
The study results reported a high prevalence of 
metabolic syndrome criteria among subjects with 
metabolic syndrome. The most frequently observed 
component of metabolic syndrome was found to be 
Fasting Blood Glucose (FBG), followed by HDL-C 
(Table 5). According to the study findings, HDL-C had 
significant relationship between men and women (P-
value<0.001).  
However, there was not statistically significant 
between men and women in other metabolic syndrome 
criteria (Table 6). There were not statistically 
significant between the khat chewing and metabolic 
criteria. In addition, there were not statistically 
significant between the metabolic syndrome and khat 
chewing. 
 
DISCUSSION 
Metabolic syndrome is a serious health problem and its 
prevalence increasing globally. To our knowledge, this 
is the first Yemeni study that focuses on the estimation 
of the prevalence of metabolic syndrome in the general 
population by using the American Heart 
Association/National Heart, Lung, and Blood Institute 
(AHA/NHLBI) and to a joint statement from several 
large organizations. According to the study results, the 
prevalence of metabolic syndrome was seen in 40 % of 
the study subjects. This result is consistent with results 
from other studies, where the prevalence of metabolic 
syndrome was 38.5% among Americans
12 
and of 33.5% 
in the population of India
13
. However; it is high 
compared to prevalence in the South African 
population
14 
(25.5%) and lower than that of the 
population of Nepal
 
(61.7%)
15
. These differences in the 
prevalence can be explained by the interaction of 
genetic and environmental factors, which have long 
been known to play a key role in the pathophysiology 
of metabolic syndrome
16
. Furthermore, the study of the 
metabolic syndrome prevalence according to sex 
showed a significantly higher prevalence in females 
(52.9%) %) compared to males (30.4%). This result is 
similar to many studies
17,18
. However, it was in 
consistent with others where the prevalence is similar 
between both sexes
19
. Factors such as weight gain after 
pregnancy, diabetes mellitus during pregnancy, 
polycystic ovary syndrome, preeclampsia, use of 
hormonal contraceptives, and menopause may increase 
the risk of metabolic syndrome in women
20
. In 
addition, we observed a variation in the prevalence of 
metabolic syndrome according to age with a maximum 
at the fourth decade among the study sample 
(62.5%).This may be related to the most study subjects 
within this age group (64.2%). A decline was observed 
in the prevalence of metabolic syndrome in patients 
aged over 60 years. This may be related to the increase 
of the mortality in people with metabolic syndrome of 
>=60 years old. Moreover, the association between 
premature mortality and the presence of metabolic 
syndrome has been described in many studies
17, 21
. Also 
the lack of consensus on metabolic syndromes 
definitions and the cutoff points used for its 
components, especially regarding waist circumference, 
has resulted in these differences. The comparisons 
between Yemen and other countries must be made with 
caution. Because in Yemen and most of other studies 
were conducted in a small area or a city, they cannot be 
representative of the whole country. Therefore, 
generalizing the study results to all population is a 
point of concern
22
. Also the differences between people 
might to genetic variations that could effect on 
metabolic syndrome criteria
23
. 
In terms of individual criteria, the major factors 
contributing to metabolic syndrome were fasting blood 
glucose (85%), followed by HDL-C and triglyceride 
(77.1% and 67.6%; respectively). These findings could 
be associated with the high prevalence of insulin 
resistance and the propensity for elevated triglyceride 
levels in patients with metabolic syndrome. 
Furthermore, about 34.2% of participants in the sample 
survey were unaware of pre-existing diabetes of.  
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Table 6: Distribution of metabolic syndrome criteria according to gender 
Variable Gender 
Male          Female 
Total P-value 
TG <150 mg/dl 41 28 69  
0.621 150 mg/dL or greater 28 23 51 
HDL-C <40 mg/dl in men or <50 in 
women 
30 39 69  
0.001 
40 mg/dL or greater in men 
or = 50 or greater in women 
39 12 51 
Waist 
circumference 
<89 cm in women or <102 
cm in men 
51 31 82  
0.13 
89 cm in women or greater 
or 102 cm or greater in men 
18 
(26.1%) 
20 
(39.2%) 
38 
Fasting Blood 
Glucose 
<100 mg/dL 28 18 46 0.56 
100 mg/dL or greater 41 33 74 
Blood pressure <130/85 mm 43 38 81 0.16 
130/85 mm Hg or greater 26 13 39 
 
Table 7: Distribution of metabolic syndrome criteria among subjects with khat chewing 
Variable Khat chewing  
P-value Yes  No  
 
Waist Circumference 
No 51 31  
0.92 Yes 24 14 
 
Triglyceride 
No 39 30  
0.12 Yes 36 15 
 
HDL-C 
Yes 41 28  
0.42 No 34 17 
 
Blood Pressure 
No 46 35  
0.062 Yes 29 39 
Fasting Blood 
Glucose 
Yes 48 26  
0.50 No 27 19 
 
After evaluation, 85% in this group were eventually 
diagnosed with metabolic syndrome. In a study 
conducted by Delavari et al.
24
, greater waist 
circumference values and lower HDL cholesterol have 
also been reported in Iranian communities than in 
Western populations, which support the idea of an 
ethnic predisposition of the Iranian community to 
metabolic syndrome. 
In the current study, there were not statistically 
significant between the khat chewing and metabolic 
criteria or the prevalence of metabolic syndrome. This 
might due to other classical cardiovascular risk factors, 
such as smoking, dietary salt intake, physical 
inactivity, and other habits along with Khat may 
modify the extent of association between Khat chewing 
and metabolic criteria. In contrast to previous studies, 
Khat chewing had a significant effect on carbohydrate 
metabolism by a reduced insulin secretion, insulin 
resistance
25,26 
and cathinone-induced catecholamines 
secretion; which would raise blood glucose levels
27
. 
A study conducted to investigate the effect of khat 
chewing on the blood glucose level of normal chewers 
in comparison to the effects of two antidiabetic drugs 
in diabetic patients showed that the percentage of sugar 
decrease in khat chewers without diabetes was 
significantly higher than the effect of the two 
antidiabetic drugs
28
. Recently, a study done by Murray 
et al.
 
reported that khat chewing significantly decreased 
the sensation of hunger and increase the feelings of 
fullness
29
.  
 
Moreover, it was found one of khat uses is in the 
control of obesity, which indirectly would decrease the 
risk of diabetes. High plasma levels leptin, have been 
found 4 hours after a heavy khat chewing session 
(400g). This hormone may attribute to the decreased of 
appetite and body weight that observed in khat 
chewers
30
. 
 
CONCLUSION 
In conclusion, this study places Yemen as one of the 
countries with the highest prevalence of metabolic 
syndrome. The risk factors for metabolic syndrome in 
Yemeni populations were similar to those reported 
internationally. In addition, women were at a greater 
risk of having metabolic syndrome. The major causes 
of metabolic syndrome are unhealthy lifestyles and 
eating habits.  
This emphasizes the need for more attention to 
evaluate this condition to decreasing the prevalence of 
cardiovascular morbidity and mortality in these 
subjects. Furthermore, in order to prevent metabolic 
syndrome, policy makers should consider the 
promotion of a healthy diet and physical activity in the 
future strategies of health care of Yemeni population. 
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